Bladder and bowel dysfunction
Conditions
Interventions
Experimental group:Sacral neuromodulation intervention
Sponsors
The Sixth Affiliated Hospital of Sun Yat-Sen University
Eligibility
Sex/Gender
All
Age
18 Years to 90 Years
Inclusion criteria
Inclusion criteria: 1. Aged >=18 years; 2. Clinically diagnosed with BBD [Consistent with the diagnosis of BBD (at least one symptom group of lower urinary tract symptoms and at least one intestinal symptom (such as constipation, diarrhea, fecal incontinence, etc.) co-occurring), confirmed by objective assessment (defecography + urodynamic testing)]; 3. Voluntarily participate in this study, and the patients themselves or their legal representatives sign the informed consent.
Exclusion criteria
Exclusion criteria: 1. Allergy to sacral nerve stimulator consumables; 2. Have a history of other tumors, coronary heart disease, liver cirrhosis, renal insufficiency, etc., and suffer from blood diseases, including various types of leukemia and bleeding diseases; 3. There is severe anxiety and severe cognitive impairment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Symptom improvement; | — |
Countries
China
Contacts
Public ContactRen Donglin
Outcome results
None listed